Skip to main content
An official website of the United States government

Early Detection and Screening Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
NCI Clinical and Translational Exploratory/Developmental Studies PAR-25-139 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 10/07/2025 Marjorie Perloff, M.D.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes PAR-25-095 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 09/07/2026 Wendy Wang, Ph.D., M.Sc.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-25-074 (UH2/UH3 Clinical Trial Not Allowed) UH2, UH3 Clinical Trial Not Allowed 10/14/2026 Sudhir Srivastava, Ph.D., M.P.H.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-25-075 (UH3 Clinical Trials Not Allowed) UH3 10/14/2026 Sudhir Srivastava, Ph.D., M.P.H.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-288 (K99/R00 - Independent Basic Experimental Studies with Humans Required) R00, K99 10/15/2026 Asad Umar, D.V.M., Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed) R00, K99 Clinical Trial Not Allowed 10/15/2026 Asad Umar, D.V.M., Ph.D.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-287 (K99/R00 - Independent Clinical Trial Required) R00, K99 Clinical Trial Required 10/15/2026 Asad Umar, D.V.M., Ph.D.
Cancer Prevention and Control Clinical Trials Grant Program PAR-25-167 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/07/2027 Goli Samimi, Ph.D., M.P.H.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis PAR-25-081 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/07/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research PAR-24-153 (K12 Clinical Trial Optional) K12 Clinical Trial Optional 02/19/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.